This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Newron Pharmaceuticals S.p.a., Vicuron Pharmaceuticals Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Petra Karin Kaltofen: Innovator in Hydroxylamine Derivatives
Introduction
Petra Karin Kaltofen is a notable inventor based in Milan, Italy. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work on hydroxylamine derivatives. Her research focuses on developing compounds that can aid in the prevention, treatment, and diagnosis of central nervous system degenerative disorders.
Latest Patents
Kaltofen holds a patent for hydroxylamine derivatives, which are characterized by a general formula that includes various substituents. This invention is particularly relevant for its potential applications in creating medicaments that address issues related to protein misfolding and misaggregation. The patent also encompasses novel compounds, methods for their preparation, and pharmaceutical compositions that incorporate these compounds.
Career Highlights
Throughout her career, Petra has worked with prominent companies in the pharmaceutical industry, including Newron Pharmaceuticals S.p.a. and Vicuron Pharmaceuticals Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Kaltofen has collaborated with notable colleagues such as Carla Caccia and Laura Girola. These partnerships have further enhanced her research and development efforts in the pharmaceutical sector.
Conclusion
Petra Karin Kaltofen's work on hydroxylamine derivatives represents a significant advancement in the field of medicinal chemistry. Her innovative contributions have the potential to impact the treatment of CNS degenerative disorders, showcasing her role as a key inventor in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile